Yin Shuai, Bleul Tim, Zhu Yifan, Isayev Orkhan, Werner Jens, Bazhin Alexandr V
Department of General, Visceral, and Transplantation Surgery, University Hospital of the LMU, Munich, Germany.
Department of Oncology, Henan University Huaihe Hospital, Kai Feng, China.
Cell Physiol Biochem. 2017;44(2):644-656. doi: 10.1159/000485276. Epub 2017 Nov 24.
BACKGROUND/AIMS: Retinoid receptors and retinoic acid were reported to be down-regulated in pancreatic duct adenocarcinoma (PDAC) compared to normal pancreas. Yet the mechanism of the down-regulation of retinoid receptors is not well defined. The aim of this study was to find out whether selected dysregulated miRNAs in PDAC are responsible for the decreased level of retinoid receptors.
Bioinformatics, real-time PCR, western blot analysis as well as molecular manipulation with miRNA in cells of PDAC were carried out.
We first performed bioinformatics research to identify conserved target sequences for deregulated miRNAs within the 3'UTR region of retinoid receptor mRNA. This research revealed binding sites for miR-138, -27a, -27b, -206, -613, -9-5p, -27a/b-3p and -27a. Next, we investigated the expression of selected retinoid receptors and miRNAs in PDAC cell lines and in the Human Pancreatic Duct Epithelial (HPDE) cell line. Further, we investigated the effects of modifying expression levels of selected miRNAs using miRNA inhibitors or mimics. We demonstrated that none of these miRNAs can target the selected retinoid receptors in vitro.
miR-27a, miR-27b, miR-9, miR10a and miR-10b were up-regulated in PDAC cells compared to HPDE cells. The up-regulation of these miRNAs was not responsible for the down-regulation of RARα, RARβ, RXRα and RXRβ in PDAC cells.
背景/目的:与正常胰腺相比,类视黄醇受体和视黄酸在胰腺导管腺癌(PDAC)中表达下调。然而,类视黄醇受体下调的机制尚未明确。本研究旨在探究PDAC中某些失调的微小RNA(miRNA)是否导致类视黄醇受体水平降低。
进行了生物信息学分析、实时聚合酶链反应(PCR)、蛋白质免疫印迹分析以及对PDAC细胞中的miRNA进行分子操作。
我们首先进行生物信息学研究,以确定类视黄醇受体mRNA的3'非翻译区(UTR)内失调miRNA的保守靶序列。该研究揭示了miR-138、-27a、-27b、-206、-613、-9-5p、-27a/b-3p和-27a的结合位点。接下来,我们研究了选定的类视黄醇受体和miRNA在PDAC细胞系以及人胰腺导管上皮(HPDE)细胞系中的表达。此外,我们使用miRNA抑制剂或模拟物研究了改变选定miRNA表达水平的影响。我们证明,在体外这些miRNA均不能靶向选定的类视黄醇受体。
与HPDE细胞相比,miR-27a、miR-27b、miR-9、miR10a和miR-10b在PDAC细胞中上调。这些miRNA的上调并非导致PDAC细胞中维甲酸受体α(RARα)、维甲酸受体β(RARβ)、维甲酸X受体α(RXRα)和维甲酸X受体β(RXRβ)下调的原因。